TNF and neoplasm: CM was produced through activating astrocytes either by co-culturing them in the presence of the tumor cells (CM: A 231BR) or by treatment with IFNγ and TNFα (CM: A IFNγ + TNFα), two agents known to activate astrocytes [18].